met signaling in nsclc: challenges and opportunities for biomarker development and drug discovery
Published 3 years ago • 652 plays • Length 49:28Download video MP4
Download video MP3
Similar videos
-
45:50
practical principles of biomarker testing in advanced non-small cell lung cancer
-
5:04
c-met role as biomarker and player in innate and acquired resistance in non-small-cell lung cancer
-
36:48
personalized therapy for nsclc: biomarker testing, treatment & management in met alterations
-
7:18
navigating nsclc: merging molecular insights and targeted therapy | biomarker-guided therapy in n...
-
4:18
when should biomarker testing be done in nsclc?
-
4:50
nsclc: challenges with pd-l1 as biomarker
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
0:55
challenges associated with biomarker testing for pd-l1 in nsclc
-
3:23
navigating lung cancer biomarker testing | challenges and solutions for timely access
-
1:14:14
fine-tuning biomarker testing to identify and target ret fusions in nsclc
-
7:00
landscape of biomarker testing for nsclc
-
1:05
the challenge of biomarkers in lung cancer
-
0:46
clinical trials and lung cancer biomarkers
-
1:31
dr. akerley on met biomarker in lung cancer
-
6:22
biomarker testing in stage iii nsclc
-
5:50
understanding biomarkers
-
2:28
empowered by biomarker testing: amber’s journey with stage iv nsclc
-
44:25
biomarker testing and onco-gene driven lung cancer